Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

24.07.2026

Extensior Launch Cuts Ozempic Cost By 15%

The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand.

This article is for Health Matters subscribers

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

Subscribe Log in

Not ready to subscribe? Get Health Matters Weekly free: the week’s top healthcare headlines every Friday.

Discovery Health, Extensior, GLP-1 Medicines, Medical Schemes, Medicine Pricing, Novo Nordisk, ozempic, semaglutide, South African healthcare, Type 2 Diabetes

More from Health Matters

12.11.2026

Generic Semaglutide From Aspen Wins Approval in South Africa and Brazil

Aspen wins generic semaglutide approval in South Africa and Brazil, with launches planned in coming months. Read what this means for diabetes care.

12.11.2026

Diabetes Care Faces New Scrutiny as the Diabetes Alliance Launches an Accountability Framework

Learn why the Diabetes Alliance is launching a framework to track diabetes care commitments as South Africa's 2027 NCD targets rapidly approach.

12.11.2026

ARV Tender Ruling Faces an Appeal From Viatris and Innovata

Learn why Viatris and Innovata are seeking leave to appeal the ARV tender ruling that set aside their TLD contracts, and what it means for supply.